The estimated Net Worth of Rodger Novak is at least $10,072,241.01. Rodger Novak owns over 698,007 units of CRISPR Therapeutics AG stock worth over $10,072,241.01.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 30th November 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Exercise of derivative | 698,007 | $14.43 | $721,500.00 | $10,072,241.01 |
| 30th November 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 648,007 | $125.00 | $6,250,000.00 | $81,000,875.00 |
| 30th November 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Exercise of derivative | 698,007 | $14.00 | $700,000.00 | $9,772,098.00 |
| 9th October 2020 | CRSP - CRISPR Therapeutics AG | 2,762 | Open or private sale | 648,007 | $100.00 | $276,200.00 | $64,800,700.00 |
| 9th October 2020 | CRSP - CRISPR Therapeutics AG | 2,762 | Exercise of derivative | 650,769 | $14.43 | $39,855.66 | $9,390,596.67 |
| 8th October 2020 | CRSP - CRISPR Therapeutics AG | 22,238 | Open or private sale | 648,007 | $100.00 | $2,223,800.00 | $64,800,700.00 |
| 8th October 2020 | CRSP - CRISPR Therapeutics AG | 22,238 | Exercise of derivative | 670,245 | $14.43 | $320,894.34 | $9,671,635.35 |
| 9th January 2019 | CRSP - CRISPR Therapeutics AG | 82,690 | Open or private sale | 1,048,007 | $35.01 | $2,894,976.90 | $36,690,725.07 |
| 8th January 2019 | CRSP - CRISPR Therapeutics AG | 17,310 | Open or private sale | 1,130,697 | $35.09 | $607,407.90 | $39,676,157.73 |
| 25th February 2019 | CRSP - CRISPR Therapeutics AG | 14,780 | Open or private sale | 1,033,227 | $40.00 | $591,232.52 | $41,331,353.10 |
| 4th March 2019 | CRSP - CRISPR Therapeutics AG | 3,500 | Open or private sale | 948,007 | $42.03 | $147,105.00 | $39,844,734.21 |
| 4th March 2019 | CRSP - CRISPR Therapeutics AG | 8,912 | Open or private sale | 951,507 | $41.29 | $367,948.85 | $39,284,774.36 |
| 4th March 2019 | CRSP - CRISPR Therapeutics AG | 64,115 | Open or private sale | 960,419 | $40.24 | $2,580,186.36 | $38,650,237.86 |
| 1st March 2019 | CRSP - CRISPR Therapeutics AG | 8,693 | Open or private sale | 1,024,534 | $40.01 | $347,796.50 | $40,990,375.90 |
| 10th June 2019 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 898,007 | $45.00 | $2,250,000.00 | $40,410,315.00 |
| 10th July 2019 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 848,007 | $50.00 | $2,500,065.00 | $42,401,452.41 |
| 19th November 2019 | CRSP - CRISPR Therapeutics AG | 33,618 | Open or private sale | 0 | $70.00 | $2,353,260.00 | $0.00 |
| 19th November 2019 | CRSP - CRISPR Therapeutics AG | 33,618 | Exercise of derivative | 33,618 | $14.43 | $485,107.74 | $485,107.74 |
| 19th May 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 798,007 | $65.00 | $3,250,000.00 | $51,870,455.00 |
| 26th May 2020 | CRSP - CRISPR Therapeutics AG | 36,616 | Open or private sale | 748,007 | $70.27 | $2,573,006.32 | $52,562,451.89 |
| 22nd May 2020 | CRSP - CRISPR Therapeutics AG | 13,384 | Open or private sale | 784,623 | $70.01 | $937,013.84 | $54,931,456.23 |
| 23rd June 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 698,007 | $75.00 | $3,750,000.00 | $52,350,525.00 |
| 1st July 2020 | CRSP - CRISPR Therapeutics AG | 50,000 | Open or private sale | 648,007 | $80.00 | $4,000,000.00 | $51,840,560.00 |
| 7th July 2020 | CRSP - CRISPR Therapeutics AG | 25,000 | Open or private sale | 648,007 | $90.00 | $2,250,000.00 | $58,320,630.00 |
| 7th July 2020 | CRSP - CRISPR Therapeutics AG | 19,414 | Exercise of derivative | 673,007 | $14.00 | $271,796.00 | $9,422,098.00 |
| 7th July 2020 | CRSP - CRISPR Therapeutics AG | 5,586 | Exercise of derivative | 653,593 | $1.81 | $10,110.66 | $1,183,003.33 |
| 19th August 2020 | CRSP - CRISPR Therapeutics AG | 25,000 | Open or private sale | 648,007 | $100.00 | $2,500,000.00 | $64,800,700.00 |
| 19th August 2020 | CRSP - CRISPR Therapeutics AG | 25,000 | Exercise of derivative | 673,007 | $14.00 | $350,000.00 | $9,422,098.00 |
| 1st September 2020 | CRSP - CRISPR Therapeutics AG | 3,840 | Open or private sale | 648,007 | $93.19 | $357,849.60 | $60,387,772.33 |
| 1st September 2020 | CRSP - CRISPR Therapeutics AG | 19,754 | Open or private sale | 651,847 | $92.59 | $1,829,022.86 | $60,354,513.73 |
| 1st September 2020 | CRSP - CRISPR Therapeutics AG | 1,406 | Open or private sale | 671,601 | $91.54 | $128,705.24 | $61,478,355.54 |
| 1st September 2020 | CRSP - CRISPR Therapeutics AG | 21,067 | Exercise of derivative | 673,007 | $14.43 | $303,996.81 | $9,711,491.01 |
| 1st September 2020 | CRSP - CRISPR Therapeutics AG | 3,933 | Exercise of derivative | 651,940 | $14.00 | $55,062.00 | $9,127,160.00 |